Virtus ETF Advisers’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Virtus ETF Advisers's NVS Position: Q2 2026 in Review
Virtus ETF Advisers increased its Novartis (NVS) stake by 257% in Q2 2026, buying an estimated $2.7K and bringing the position to 25 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #490.
Virtus ETF Advisers first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,624 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Virtus ETF Advisers held 25 shares of Novartis worth $3.92K as of Q2 2026.
- Virtus ETF Advisers bought 18 Novartis shares in Q2 2026, an estimated $2.7K.
- Novartis made up ﹤0.01% of Virtus ETF Advisers's portfolio in Q2 2026, its #490 holding.
- Virtus ETF Advisers first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
- 1,624 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.